Sorting and secreting insulin by expiration date
The age of insulin parcels may matter, researchers say, when it comes to diagnosing and treating diabetes.
Read moreType 2 Diabetes
3D printed insoles offers new hope for patients with diabetes
Scientists from Staffordshire University claim that new 3D printed insoles can significantly improve the foot health of people suffering with diabetes.
Read morePromising treatment to slow kidney disease doesn’t prove out in clinical trial
Scientists find that reducing levels of uric acid in the blood does not guard against complication in type 1 diabetes.
Read more3D printed insoles offers new hope for patients with diabetes
Scientists from Staffordshire University claim that new 3D printed insoles can significantly improve the foot health of people suffering with diabetes.
Read morePromising treatment to slow kidney disease doesn’t prove out in clinical trial
Scientists find that reducing levels of uric acid in the blood does not guard against complication in type 1 diabetes.
Read moreShould diabetes treatment lessen for older adults approaching the end of life?
Journal of the American Geriatrics Society Research Summary
Read moreShould diabetes treatment lessen for older adults approaching the end of life?
Journal of the American Geriatrics Society Research Summary
Read morePCORI Board approves up to $50 million in funding for COVID-19 research
$25 million to support 10 new research studies
Read moreChemist develops potential drug to treat type 2 diabetes without harsh side effects
Syracuse, N.Y. – Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type
Read moreStatement on metabolic and bariatric surgery during COVID-19 pandemic
American Society for Metabolic and Bariatric Surgery (ASMBS) calls for safe resumption of bariatric and metabolic surgery before COVID-19 pandemic is declared over
Read morePCORI Board approves up to $50 million in funding for COVID-19 research
$25 million to support 10 new research studies
Read moreChemist develops potential drug to treat type 2 diabetes without harsh side effects
Syracuse, N.Y. – Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type
Read more